Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Yuan

Showing results (51-60 of 1,843) with videos related to

Pageof 185
Sort By:
Biometrics|September 2, 2008
Mixed-effect hybrid models for longitudinal data with nonignorable dropoutYing Yuan, Roderick J A Little
The Annals of Applied Statistics|April 8, 2014
BAYESIAN DATA AUGMENTATION DOSE FINDING WITH CONTINUAL REASSESSMENT METHOD AND DELAYED TOXICITYSuyu Liu, Guosheng Yin, Ying Yuan
Bayesian Analysis|August 20, 2013
Bayesian Dose Finding for Combined Drugs with Discrete and Continuous DosesLin Huo, Ying Yuan, Guosheng Yin
Pharmaceutical Statistics|April 6, 2020
Bayesian adaptive linearization method for phase I drug combination trials with dimension reductionHaitao Pan, Cheng Cheng, Ying Yuan
Clinical and Experimental Medicine|August 26, 2022
Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinomaJiaqi Chen, Ding Zhang, Ying Yuan
Contemporary Clinical Trials|September 10, 2021
Elastic meta-analytic-predictive prior for dynamically borrowing information from historical data with application to biosimilar clinical trialsWen Zhang, Zhiying Pan, Ying Yuan
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 9, 2025
Natural disaster, ESG investing, and financial contagionHaiying Wang, Ying Yuan, Tianyang Wang
Medical Review (2021)|January 29, 2024
Bayesian approach for design and analysis of medical device trials in the era of modern clinical studiesHan Cao, Chen Yao, Ying Yuan
Clinical Trials (London, England)|January 20, 2024
Statistical and practical considerations in planning and conduct of dose-optimization trialsYing Yuan, Heng Zhou, Suyu Liu
Journal of Cancer Research and Clinical Oncology|June 4, 2024
Butyrate inhibits the malignant biological behaviors of breast cancer cells by facilitating cuproptosis-associated gene expressionLiming Zhang, Shan Huang, Ying Yuan
Pageof 185

Showing results (51-60 of 1,843) with videos related to

Sort By:
Pageof 185
Biometrics|September 2, 2008
Mixed-effect hybrid models for longitudinal data with nonignorable dropoutYing Yuan, Roderick J A Little
The Annals of Applied Statistics|April 8, 2014
BAYESIAN DATA AUGMENTATION DOSE FINDING WITH CONTINUAL REASSESSMENT METHOD AND DELAYED TOXICITYSuyu Liu, Guosheng Yin, Ying Yuan
Bayesian Analysis|August 20, 2013
Bayesian Dose Finding for Combined Drugs with Discrete and Continuous DosesLin Huo, Ying Yuan, Guosheng Yin
Pharmaceutical Statistics|April 6, 2020
Bayesian adaptive linearization method for phase I drug combination trials with dimension reductionHaitao Pan, Cheng Cheng, Ying Yuan
Clinical and Experimental Medicine|August 26, 2022
Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinomaJiaqi Chen, Ding Zhang, Ying Yuan
Contemporary Clinical Trials|September 10, 2021
Elastic meta-analytic-predictive prior for dynamically borrowing information from historical data with application to biosimilar clinical trialsWen Zhang, Zhiying Pan, Ying Yuan
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 9, 2025
Natural disaster, ESG investing, and financial contagionHaiying Wang, Ying Yuan, Tianyang Wang
Medical Review (2021)|January 29, 2024
Bayesian approach for design and analysis of medical device trials in the era of modern clinical studiesHan Cao, Chen Yao, Ying Yuan
Clinical Trials (London, England)|January 20, 2024
Statistical and practical considerations in planning and conduct of dose-optimization trialsYing Yuan, Heng Zhou, Suyu Liu
Journal of Cancer Research and Clinical Oncology|June 4, 2024
Butyrate inhibits the malignant biological behaviors of breast cancer cells by facilitating cuproptosis-associated gene expressionLiming Zhang, Shan Huang, Ying Yuan
Pageof 185